Chk1 suppresses bypass of mitosis and tetraploidization in p53-deficient cancer cells

被引:10
|
作者
Wilsker, Deborah [2 ]
Chung, Jon H. [1 ]
Bunz, Fred [1 ]
机构
[1] Johns Hopkins Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA
[2] NCI, Mol Radiat Therapeut Branch, SAIC Frederick, Frederick, MD 21701 USA
关键词
p53; Chk1; tetraploid; mitosis; DNA-DAMAGE CHECKPOINT; CHROMOSOMAL INSTABILITY; GENETIC INSTABILITY; KINASE; ATR; PHOSPHORYLATION; PROTEIN; REPLICATION; INACTIVATION; INHIBITION;
D O I
10.4161/cc.19944
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Many cancer cells are unable to maintain a numerically stable chromosome complement. It is well established that aberrant cell division can generate progeny with increased ploidy, but the genetic factors required for maintenance of diploidy are not well understood. Using an isogenic model system derived by gene targeting, we examined the role of Chk1 in p53-proficient and -deficient cancer cells. Targeted inactivation of a single CHK1 allele in stably diploid cells caused an elevated frequency of mitotic bypass if p53 was naturally mutated or experimentally disrupted by homologous recombination. CHK1-haploinsufficient, p53-deficient cells frequently underwent sequential rounds of DNA synthesis without an intervening mitosis. These aberrant cell cycles resulted in whole-genome endoreduplication and tetraploidization. The unscheduled bypass of mitosis could be suppressed by targeted reversion of a p53 mutation or by exogenous expression of Cdk1. In contrast, the number of tetraploid cells was not increased in isogenic cell populations that harbor hypomorphic ATR mutations, suggesting that suppression of unscheduled mitotic bypass is a distinct function of Chk1. These results are consistent with a recently described role for Chk1 in promoting the expression of genes that promote cell cycle transitions and demonstrate how Chk1 might prevent tetraploidization during the cancer cell cycle.
引用
收藏
页码:1564 / 1572
页数:9
相关论文
共 50 条
  • [41] The anticancer effects of Aronia berry extract are mediated by Chk1 and p53 in colorectal cancer
    Asahi, Yoh
    Xu, Caiming
    Okuno, Keisuke
    Taketomi, Akinobu
    Goel, Ajay
    PHYTOMEDICINE, 2024, 135
  • [42] The p53-deficient mouse: A model for basic and applied cancer studies
    Donehower, LA
    SEMINARS IN CANCER BIOLOGY, 1996, 7 (05) : 269 - 278
  • [43] Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
    Reaper P.M.
    Griffiths M.R.
    Long J.M.
    Charrier J.-D.
    MacCormick S.
    Charlton P.A.
    Golec J.M.C.
    Pollard J.R.
    Nature Chemical Biology, 2011, 7 (7) : 428 - 430
  • [44] Inhibition of ATR-dependent feedback activation of Chk1 sensitises cancer cells to Chk1 inhibitor monotherapy
    Massey, Andrew J.
    CANCER LETTERS, 2016, 383 (01) : 41 - 52
  • [45] Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells
    Kigawa, J
    Sato, S
    Shimada, M
    Kanamori, Y
    Itamochi, H
    Terakawa, N
    GYNECOLOGIC ONCOLOGY, 2002, 84 (02) : 210 - 215
  • [46] MdmX regulates transformation and chromosomal stability in p53-deficient cells
    Matijasevic, Zdenka
    Krzywicka-Racka, Anna
    Sluder, Greenfield
    Jones, Stephen N.
    CELL CYCLE, 2008, 7 (19) : 2967 - 2973
  • [47] Correlation of gemcitabine sensitization by Chk1 inhibition with p53 status
    Pan, Shanlong
    Li, Rongrong
    Tao, Li
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (03) : 270 - 274
  • [48] Tissue-specific regulation of Chk1 expression by p53
    Cheung, KJ
    Li, G
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2001, 71 (02) : 156 - 160
  • [49] Securinine induces p73-dependent apoptosis preferentially in p53-deficient colon cancer cells
    Rana, Sonia
    Gupta, Kalpana
    Gomez, Jose
    Matsuyama, Shigemi
    Chakrabarti, Amitabha
    Agarwal, Munna L.
    Agarwal, Anju
    Agarwal, Mukesh K.
    Wald, David N.
    FASEB JOURNAL, 2010, 24 (06): : 2126 - 2134
  • [50] Multiple Defects Sensitize p53-Deficient Head and Neck Cancer Cells to the WEE1 Kinase Inhibition
    Diab, Ahmed
    Kao, Michael
    Kehrli, Keffy
    Kim, Hee Yeon
    Sidorova, Julia
    Mendez, Eduardo
    MOLECULAR CANCER RESEARCH, 2019, 17 (05) : 1115 - 1128